Literature DB >> 26238736

Expression profile analysis of microRNAs and downregulated miR-486-5p and miR-30a-5p in non-small cell lung cancer.

Jianjie Zhu1, Yuanyuan Zeng1, Chun Xu2, Hualong Qin2, Zhe Lei3, Dan Shen1, Zeyi Liu1, Jian-An Huang1.   

Abstract

Lung cancer is the leading cause of cancer-related mortality worldwide and although there have been improvements in treatment there is a low survival rate. The aim of the present study was to investigate the effect of microRNA (miRNA) on cell pathways. A miRNA microarray was used to profile miRNAs of lung cancer tissues. It was identified that 33 miRNAs with >2.0-fold change and FDR <0.05 were differentially expressed between the adjacent non-cancerous lung tissues and non-small cell lung cancers NSCLCs (P<0.005). The data were optimized in combination with physical interaction analysis to obtain crucial miRNAs. The results showed that differentially expressed miRNAs were associated with biological processes such as cell migration, protein phosphorylation and neuron differentiation, and signaling pathways such as MAPK, TGF-β and PI3K/Akt signaling pathways. Validation of significant miRNAs in independent 40 paired NSCLC tissues demonstrated that the expression level of miR-486-5p and miR-30a-5p was significantly downregulated in another 40 paired lung cancer tissues. Taken together, the results provided strong evidence of the possible involvement of miRNAs in the development and progression of NSCLC. Thus, the results are of importance for clinical investigators and for those who design miRNA‑based novel cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26238736     DOI: 10.3892/or.2015.4141

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  31 in total

1.  MicroRNA-30a-5p suppresses proliferation, invasion and tumor growth of hepatocellular cancer cells via targeting FOXA1.

Authors:  Shuliang Zhang; Qin Liu; Qi Zhang; Ling Liu
Journal:  Oncol Lett       Date:  2017-08-10       Impact factor: 2.967

2.  Long noncoding RNA NORAD regulates lung cancer cell proliferation, apoptosis, migration, and invasion by the miR-30a-5p/ADAM19 axis.

Authors:  Jun Li; Xia Xu; Cungang Wei; Lei Liu; Tengqi Wang
Journal:  Int J Clin Exp Pathol       Date:  2020-01-01

3.  Secreted Phosphoprotein 1 Promotes the Development of Small Cell Lung Cancer Cells by Inhibiting Autophagy and Apoptosis.

Authors:  Hong Liu; Shufang Wei; Lei Zhang; Chenxi Yuan; Yuanyuan Duan; Qingwei Wang
Journal:  Pathol Oncol Res       Date:  2018-11-01       Impact factor: 3.201

Review 4.  The Role of NcRNAs to Regulate Immune Checkpoints in Cancer.

Authors:  Yicun Jiang; Leilei Zhao; Yiwen Wu; Sijun Deng; Pu Cao; Xiaoyong Lei; Xiaoyan Yang
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

5.  CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer.

Authors:  Jianjie Zhu; Yuanyuan Zeng; Wei Li; Hualong Qin; Zhe Lei; Dan Shen; Dongmei Gu; Jian-An Huang; Zeyi Liu
Journal:  Mol Cancer       Date:  2017-02-03       Impact factor: 27.401

6.  MicroRNA Expression in Malignant Pleural Mesothelioma and Asbestosis: A Pilot Study.

Authors:  Paola Mozzoni; Luca Ampollini; Matteo Goldoni; Rossella Alinovi; Marcello Tiseo; Letizia Gnetti; Paolo Carbognani; Michele Rusca; Antonio Mutti; Antonio Percesepe; Massimo Corradi
Journal:  Dis Markers       Date:  2017-07-03       Impact factor: 3.434

7.  MicroRNA-503 inhibits the proliferation and invasion of breast cancer cells via targeting insulin-like growth factor 1 receptor.

Authors:  Jingwang Yan; Yonghuan Xu; Haipeng Wang; Taiping Du; Hao Chen
Journal:  Mol Med Rep       Date:  2017-06-20       Impact factor: 2.952

8.  Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer.

Authors:  Yang Shao; Yu-Qing Shen; Yan-Li Li; Chen Liang; Bing-Jie Zhang; Sheng-Di Lu; Yan-Yun He; Ping Wang; Qiang-Ling Sun; You-Xin Jin; Zhong-Liang Ma
Journal:  Oncotarget       Date:  2016-06-07

9.  Diagnosis value of aberrantly expressed microRNA profiles in lung squamous cell carcinoma: a study based on the Cancer Genome Atlas.

Authors:  Sheng Yang; Jing Sui; Geyu Liang
Journal:  PeerJ       Date:  2017-11-30       Impact factor: 2.984

10.  Association of HMGB1 Gene Polymorphisms with Lung Cancer Susceptibility and Clinical Aspects.

Authors:  Weiwei Hu; Po-Yi Liu; Yi-Chen Yang; Po-Chun Chen; Chen-Ming Su; Chia-Chia Chao; Chih-Hsin Tang
Journal:  Int J Med Sci       Date:  2017-09-19       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.